UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2020

 

Commission File Number 000-20181

 

SAPIENS INTERNATIONAL CORPORATION N.V.

(Translation of Registrant’s name into English)

 

Azrieli Center

26 Harokmim St.

Holon, 5885800 Israel

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

 

 

 

 

 

CONTENTS

 

Exhibit No.   Title of Exhibit
99.1   Press Release

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Sapiens International Corporation N.V.

(Registrant)

     
Date: February 24, 2020 By: /s/ Roni Giladi
    Roni Giladi
    Chief Financial Officer

 

 

2

 

Exhibit 99.1 

 

 

 

Sapiens Reports Fourth Quarter and Full Year 2019 Financial Results

 

Holon, Israel, February 24, 2020 – Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), today announced its financial results for the fourth quarter and full year ended December 31, 2019.

 

Summary Results for Fourth Quarter 2019 (USD in millions, except per share data)

 

   GAAP      Non-GAAP    
   Q4-2019   Q4-2018  % Change   Q4-2019   Q4-2018   % Change 
Revenue  $86.7   $73.3    18.3%  $86.7   $73.4    18.1%
Gross Profit  $34.9   $27.9    25.3%  $38.4   $31.3    22.6%
Gross Margin   40.3%   38.0%   230bps   44.3%   42.7%   160bps
Operating Income  $10.2   $6.6    55.3%  $14.3   $10.8    32.2%
Operating Margin   11.8%   9.0%   280bps   16.5%   14.8%   170bps
Net income (*)  $6.8   $3.8    82.1%  $10.6   $7.8    34.8%
Diluted EPS  $0.13   $0.07    85.7%  $0.21   $0.16    31.3%

 

Summary Results for Full Year 2019 (USD in millions, except per share data)

 

   GAAP      Non-GAAP    
   2019   2018   % Change   2019   2018   % Change 
Revenue  $325.7   $289.7    12.4%  $325.7   $290.3    12.2%
Gross Profit  $129.5   $109.6    18.2%  $143.0   $122.9    16.3%
Gross Margin   39.8%   37.8%   200bps   43.9%   42.4%   150bps
Operating Income  $37.9   $23.0    64.5%  $52.2   $39.6    32.0%
Operating Margin   11.6%   7.9%   370bps   16.0%   13.6%   240bps
Net income (*)  $26.2   $13.8    90.4%  $38.9   $28.1    38.6%
Diluted EPS  $0.52   $0.28    85.7%  $0.77   $0.56    37.5%

 

(*)Attributable to Sapiens’ shareholders

 

“Sapiens finished 2019 on a very strong note with fourth quarter non-GAAP revenue reaching a record high of $86.7 million and non-GAAP operating margin improving by 170 basis points to 16.5%. For the full year, we advanced our business globally, growing revenue by 12.2% to $325.7 million, the high end of the annual guidance range, fueled by prior acquisitions that delivered increased market penetration with new products, particularly on the digital front. We grew our core business in both P&C, with double digit growth, and saw expansion in our L&A business towards the end of the year. Increased revenue, combined with significant operating leverage from our offshore operations, improved Sapiens 2019 non-GAAP operating margins by 240 basis points to 16.0%. This was a strong year of execution on many fronts, and I want to congratulate the Sapiens global team for their outstanding work in 2019,” stated Roni Al-Dor. president and CEO, Sapiens.

 

 

 

 

“The Sapiens global team delivered one of our most successful years to date with 34 new logos for 2019.” continued Mr. Al-Dor. Mr. Al-Dor concluded: “We are building a unified global platform of innovative digital insurance solutions and advancing our competitive position as a one-stop-shop for insurance software with enhanced products and services. The pipeline for 2020 is very robust and we see further opportunities to increase operating efficiencies and improve margins. We are introducing 2020 guidance for revenue in a range of $377 million to $383 million, and operating margin in a range of 16.0% to 16.5%.”

 

Quarterly Results Conference Call

 

Management will host a conference call and webcast today, February 24, 2020 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens’ results.

 

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

 

North America (toll-free): + 1-888-668-9141; International: +972-3- 9180609; UK: 0-800-917-5108

 

The live webcast of the call can be viewed on Sapiens’ website at: https://www.sapiens.com/investor-relations/ir-events-presentations/

 

If you are unable to join live, a replay of the call will be accessible until March 4, 2020, as follows:

 

North America: 1-888-295-2634; International: +972-3-925-5901

 

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens’ financial condition and results of operations. The Company’s management uses these non-GAAP measures to compare the Company’s performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company’s board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company’s financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation,  restructuring and cost reduction costs, tax adjustments related to non-GAAP adjustments, and acquisition-related costs, which pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

 

2

 

 

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

 

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company’s business.

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

 

The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.

 

The Company uses Adjusted EBITDA as a measurement of its operating performance, and reconciles Non-GAAP Operating Income to Adjusted EBITDA, adjusted for amortization and capitalization of capitalized software and amortization other intangible assets, stock-based compensation and acquisition-related costs, and valuation adjustment on acquired deferred revenues. The Company uses Adjusted EBITDA, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.

 

The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow while reducing the amounts for capitalization of software development costs and capital expenditures, and adds back payments related to investment in new campus in India, cash payments made for former acquisitions in respect of  future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, and were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

 

About Sapiens 

 

Sapiens International Corporation empowers insurers to succeed in an evolving industry. The company offers digital software platforms, solutions and services for the property and casualty, life, pension and annuity, reinsurance, financial and compliance, workers’ compensation and financial markets. With more than 35 years of experience delivering to over 450 organizations globally, Sapiens has a proven ability to satisfy customers’ core, data and digital requirements. For more information: www.sapiens.com

 

3

 

 

Forward Looking Statement

 

Some of the statements in this press release may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as “will,” “expects,” “believes” and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management’s current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

 

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2018, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

 

Investors and Media Contact

 

Yaffa Cohen-Ifrah
Chief Marketing Officer and Head of Corporate Communications
Sapiens International
U.S. Mobile: +1 201-250-9414
Mobile: +972 54-9099039
Email: yaffa.cohen-ifrah@sapiens.com

 

4

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Year ended 
   December 31,   December 31, 
   2019   2018   2019   2018 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
Revenue   86,715    73,311    325,674    289,707 
Cost of revenue   51,782    45,428    196,153    180,138 
                     
Gross profit   34,933    27,883    129,521    109,569 
                     
Operating expenses:                    
Research and development, net   10,233    8,284    37,378    34,414 
Selling, marketing, general and administrative   14,477    13,016    54,274    52,133 
Total operating expenses   24,710    21,300    91,652    86,547 
                     
Operating income   10,223    6,583    37,869    23,022 
                     
Financial and other expenses, net   1,019    829    2,768    3,957 
Taxes on income   2,260    1,922    8,610    5,065 
                     
Net income   6,944    3,832    26,491    14,000 
                     
Attributable to non-controlling interest   110    80    244    215 
                     
Net income attributable to Sapiens’ shareholders   6,834    3,752    26,247    13,785 
                     
Basic earnings per share   0.14    0.08    0.53    0.28 
                     
Diluted earnings per share   0.13    0.07    0.52    0.28 
                     
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   50,109    49,920    50,031    49,827 
                     
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   51,009    50,210    50,653    50,106 

 

5

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED NON-GAAP STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Year ended 
   December 31,   December 31, 
   2019   2018   2019   2018 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
Revenue   86,715    73,433    325,674    290,297 
Cost of revenue   48,313    42,113    182,662    167,353 
                     
Gross profit   38,402    31,320    143,012    122,944 
                     
Operating expenses:                    
Research and development, net   11,395    9,666    43,043    39,574 
Selling, marketing, general and administrative   12,662    10,805    47,763    43,810 
Total operating expenses   24,057    20,471    90,806    83,384 
                     
Operating income   14,345    10,849    52,206    39,560 
                     
Financial and other expenses, net   1,019    829    2,768    3,957 
Taxes on income   2,663    2,114    10,298    7,325 
                     
Net income   10,663    7,906    39,140    28,278 
                     
Attributable to non-controlling interest   110    80    244    215 
                     
Net income attributable to Sapiens’ shareholders   10,553    7,826    38,896    28,063 
                     
Basic earnings per share   0.21    0.16    0.78    0.56 
                     
Diluted earnings per share   0.21    0.16    0.77    0.56 
                     
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   50,109    49,920    50,031    49,827 
                     
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   51,009    50,210    50,653    50,106 

 

6

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Year ended 
   December 31,   December 31, 
   2019   2018   2019   2018 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
GAAP revenue   86,715    73,311    325,674    289,707 
Valuation adjustment on acquired deferred revenue   -    122    -    590 
Non-GAAP revenue   86,715    73,433    325,674    290,297 
                     
GAAP gross profit   34,933    27,883    129,521    109,569 
Valuation adjustment on acquired deferred revenue   -    122    -    590 
Amortization of capitalized software   1,499    1,247    5,668    4,859 
Amortization of other intangible assets   1,970    2,068    7,823    7,926 
Non-GAAP gross profit   38,402    31,320    143,012    122,944 
                     
GAAP operating income   10,223    6,583    37,869    23,022 
Gross profit adjustments   3,469    3,437    13,491    13,375 
Capitalization of software development   (1,162)   (1,382)   (5,665)   (5,160)
Amortization of other intangible assets   563    926    2,177    3,293 
Stock-based compensation   282    472    1,405    1,942 
Acquisition-related costs *)   970    813    2,929    3,088 
Non-GAAP operating income   14,345    10,849    52,206    39,560 
                     
GAAP net income attributable to Sapiens’ shareholders   6,834    3,752    26,247    13,785 
Operating income adjustments   4,122    4,266    14,337    16,538 
Tax and other   (403)   (192)   (1,688)   (2,260)
Non-GAAP net income attributable to Sapiens’ shareholders   10,553    7,826    38,896    28,063 

 

(*)Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and  retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

  

Summary of NON-GAAP Financial Information 
U.S. dollars in thousands (except per share amounts)

 

   Q4 2019   Q3 2019   Q2 2019   Q1 2019   Q4 2018 
                     
Revenues   86,715    82,643    79,529    76,787    73,433 
Gross profit   38,402    36,712    34,794    33,104    31,320 
Operating income   14,345    13,530    12,581    11,750    10,849 
Net income to Sapiens’ shareholders   10,553    10,412    9,541    8,390    7,826 
Adjusted EBITDA   15,271    14,523    13,358    12,524    11,797 
                          
Basic earnings per share   0.21    0.21    0.19    0.17    0.16 
Diluted earnings per share   0.21    0.21    0.19    0.17    0.16 

 

Non-GAAP Revenues by Geographic Breakdown 
U.S. dollars in thousands

 

   Q4 2019   Q3 2019   Q2 2019   Q1 2019   Q4 2018 
                     
North America   41,787    44,413    39,216    38,149    34,974 
Europe   37,504    30,273    33,881    32,193    30,850 
Asia Pacific   3,781    4,087    3,515    3,670    3,140 
South Africa   3,643    3,870    2,917    2,775    4,469 
                          
Total   86,715    82,643    79,529    76,787    73,433 

 

7

 

 

Adjusted Free Cash-Flow
U.S. dollars in thousands

 

   Q4 2019   Q3 2019   Q2 2019   Q1 2019   Q4 2018 
                     
Cash-flow from operating activities   21,429    18,671    15,507    10,550    11,509 
Increase in capitalized software development costs   (1,162)   (1,541)   (1,570)   (1,392)   (1,382)
Capital expenditures   (2,456)   (973)   (1,079)   (641)   (204)
Capital expenditures related to new campus in India   -    (6,325)   -    -    - 
Free cash-flow   17,811    9,832    12,858    8,517    9,923 
                          
Capital expenditures related to new campus in India   -    6,325    -    -    - 
Cash payments attributed to acquisition-related costs(*) (**)   200    100    1,692    1,608    790 
                          
Adjusted free cash-flow   18,011    16,257    14,550    10,125    10,713 

 

(*)Included in cash-flow from operating activities

 

(**)Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

 

Adjusted EBITDA Calculation 
U.S. dollars in thousands

 

   Three months ended   Year ended 
   December 31,   December 31, 
   2019   2018   2019   2018 
                 
GAAP operating profit   10,223    6,583    37,869    23,022 
                     
Non-GAAP adjustments:                    
Amortization of capitalized software   1,499    1,247    5,668    4,859 
Amortization of other intangible assets   2,533    2,994    10,000    11,219 
Capitalization of software development   (1,162)   (1,382)   (5,665)   (5,160)
Stock-based compensation   282    472    1,405    1,942 
Acquisition-related costs   970    813    2,929    3,088 
Valuation adjustment on acquired deferred revenue   -    122    -    590 
                     
Non-GAAP operating profit   14,345    10,849    52,206    39,560 
                     
Depreciation   926    948    3,470    3,784 
                     
Adjusted EBITDA   15,271    11,797    55,676    43,344 

 

8

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands

 

   December 31,   December 31, 
   2019   2018 
   (unaudited)   (unaudited) 
         
ASSETS        
         
CURRENT ASSETS        
Cash and cash equivalents   66,295    64,628 
Trade receivables, net and unbilled receivables   50,221    59,159 
Investment in deposit   22,890    - 
Other receivables and prepaid expenses   7,817    6,224 
           
Total current assets   147,223    130,011 
           
LONG-TERM ASSETS          
Property and equipment, net   16,601    8,515 
Severance pay fund   5,106    4,699 
Goodwill and intangible assets, net   228,691    231,348 
Operating lease right-of-use assets   49,539    - 
Other long-term assets   5,261    4,292 
           
Total long-term assets   305,198    248,854 
           
TOTAL ASSETS   452,421    378,865 
           
LIABILITIES AND EQUITY          
           
CURRENT LIABILITIES          
Trade payables   5,107    6,149 
Current maturities of Series B Debentures   9,898    9,898 
Accrued expenses and other liabilities   60,574    46,999 
Current maturities of operating lease liabilities   8,312    - 
Deferred revenue   21,021    18,057 
           
Total current liabilities   104,912    81,103 
           
LONG-TERM LIABILITIES          
Series B Debentures, net of current maturities   58,850    68,577 
Deferred tax liabilities   5,082    11,681 
Other long-term liabilities   8,321    9,398 
Long-term operating lease liabilities   43,394    - 
Accrued severance pay   6,364    5,622 
           
Total long-term liabilities   122,011    95,278 
           
EQUITY   225,498    202,484 
           
TOTAL LIABILITIES AND EQUITY   452,421    378,865 

 

9

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands

 

   For the twelve months ended
December 31,
 
   2019   2018 
   (unaudited)   (unaudited) 
Cash flows from operating activities:        
Net income   26,491    14,000 
Reconciliation of net income (loss) to net cash provided by operating activities:          
Depreciation and amortization   19,138    19,862 
Accretion of discount on Series B Debentures   171    194 
Capital gain from sale of property and equipment   (40)   - 
Stock-based compensation related to options issued to employees   1,405    1,942 
           
Net changes in operating assets and liabilities, net of amount acquired:          
Trade receivables, net and unbilled receivables   10,514    (7,588)
Deferred tax assets   (6,441)   (1,567)
Other operating assets   6,726    509 
Trade payables   (1,476)   (1,870)
Other operating liabilities   6,667    (174)
Deferred revenues   2,747    2,349 
Severance pay   255    43 
           
Net cash provided by operating activities   66,157    27,700 
           
Cash flows from investing activities:          
Purchase of property and equipment   (11,474)   (1,914)
Investment in deposit   (24,009)   - 
Payments for business acquisition, net of cash acquired   (1,554)   (18,507)
Proceeds from sale of property and equipment   834    - 
Capitalized software development costs   (5,665)   (5,160)
           
Net cash used in investing activities   (41,868)   (25,581)
           
Cash flows from financing activities:          
Proceeds from employee stock options exercised   780    895 
Distribution of dividend   (11,009)   (9,978)
Repayment of Series B Debentures   (9,898)   - 
Repayment of loan   (4)   (237)
Payment of contingent considerations   (374)   (61)
Dividend to non-controlling interest   (149)   (47)
           
Net cash provided by financing activities   (20,654)   (9,428)
           
Effect of exchange rate changes on cash and cash equivalents   (1,968)   470 
           
Increase (decrease) in cash and cash equivalents   1,667    (6,839)
Cash and cash equivalents at the beginning of period   64,628    71,467 
           
Cash and cash equivalents at the end of period   66,295    64,628 

 

10

 

 

Debentures Covenants

 

As of December 31, 2019, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures that it issued in September 2017, based on having achieved the following in its consolidated financial results:

 

Covenant 1

 

Target shareholders’ equity (excluding minority interest): above $120 million.

 

Actual shareholders’ equity equal to $224 million.

 

Covenant 2

 

Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company’s Series B Debentures) bellow 65%.

 

Actual ratio of net financial indebtedness to net capitalization equal to 1.58%.

 

Covenant 3

 

Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.

 

Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to 0.07.

 

 

11